- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
505
Products in this category:
Filter Results by...
Filter Results
Species Reactivity
-
- More
Applications
-
- More
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-Ebola Nucleoprotein [KZ51]Ebola Virus (Zaire, Ivory Coast, Reston, Sudan)IP, WB, ELISA, IF
-
Anti-Ebola Nucleoprotein [MJ6]Bundibugyo), Ebola virus (Zaire, Tai ForestELISA
-
Anti-Ebola Nucleoprotein [ZE]Bundibugyo), Ebola virus (Zaire, Reston, Sudan, Tai ForestWB, ELISA
-
Anti-Ebola surface glycoprotein [KZ52]Ebola (Zaire)crystallization, IP, NTRL, IF
-
Anti-Ebola virus VP35 protein; [6c5]Zaire ebolavirusIP, Western blot, IF
-
Anti-Entry-fusion complex associated protein OPG095 [M12B9]Vaccinia virusin vivo, neutralization, ELISA, FC
-
Anti-env, Envelope glycoprotein gp160 [Fab 58.2]Human immunodeficiency virus type 1 group M subtype Bcrystallography, in vitro, neutralization, ELISA
-
Anti-env, Envelope glycoprotein gp160 [ITS090.03]Simian immunodeficiency viruscrystallography, in vitro, neutralization, ELISA
-
Anti-Envelop glycoprotein B [93k]human herpesvirus 3 (HHV-3, HHV3), Varicella zoster virus (VZV)IP, neutralize, WB
-
Anti-Envelope glycoprotein B [KE5]Human Cytomegaloviruscrystallography
-
Anti-Envelope glycoprotein E2 [F5]Venezuelan equine encephalitis virusin vitro, in vivo, neutralization, ELISA, IHC
-
Anti-Envelope glycoprotein Gc [A5]Hantaviruscrystallization, SPR
-
Anti-Envelope glycoprotein gp160 [0.5beta]Human immunodeficiency virus type 1 group M subtype Bneutralization, WB, ELISA
-
Anti-Envelope glycoprotein H and L [94]human herpesvirus 3 (HHV-3, HHV3), Varicella zoster virus (VZV)IP, neutralize, ELISA
-
Anti-Envelope glycoprotein H and L [rec-RC-IgG]Varicella zoster virus (VZV)IP, neutralize, IHC
-
Anti-Envelope protein [5A]Yellow Fever Viruscrystallography, functional assay, in vivo, IP, neutralize, ELISA
-
Anti-envelope protein [ZIKVEF2L01]Zika Virusin vitro inhibition, WB, ELISA, FC
-
Anti-envelope protein [ZIKVEF3S06]Zika Virusin vitro inhibition, WB, ELISA, FC
-
Anti-Envelope protein [ZKA64]Zika Virusenhance, NTRL, ELISA, FC
-
Anti-Envelope protein [ZKA78]Dengue Virus, Zika Virusenhance, NTRL, ELISA, FC
-
Anti-Envelope protein domain III [POWV-80]Powassan viruscrystallography, neutralizing, ELISA, FC
-
Anti-envelope protein domain IIII [Fab1]West Nile Virusin vitro, WB, ELISA, IF
-
Anti-Envelope protein E [6B6C-1]Dengue virus (DENV), Japanese encephalitis virus (JEV), St. louis encephalitis virus (SLEV), West Nile virus (WNV), Yellow fever virus (YFV)WB, ELISA
-
Anti-Envelopment polyprotein [RV-Gn3]Rift Valley fever viruscrystallography, neutralization, ELISA
-
Anti-F [ACN044]human metapneumovirusin vivo, neutralization;SPR, ELISA, IF
-
Anti-F [DS7]human metapneumovirusin vivo, neutralization;SPR, ELISA, IF
-
Anti-F glycoprotein [12B2]Nipah virusfunctional assay, neutralize
-
Anti-F protein [mAb 234]Human metapneumovirus (hMPV)neutralization, ELISA
-
Anti-F protein [mAb 338]Human metapneumovirus (hMPV)neutralization, ELISA
-
Anti-Feline Calicivirus [1D7]Feline calicivirusNTRL, ELISA